2025 Latin America Ai-Based Clinical Trials Revenue Opportunities Report
Description
The 2025 Latin America Ai-Based Clinical Trials Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the AI-based Clinical Trials by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively using AI in clinical trials with significant participation in Latin America include IQVIA, Medidata Solutions (part of Dassault Systèmes), Bioaccess, and Syneos Health. IQVIA stands out as a major global CRO leveraging AI for optimizing clinical trial design, patient recruitment, and data analysis, and has a strong presence in Latin America’s emerging markets. Medidata is a leader in AI-driven clinical trial platforms, providing tools for data management and trial execution, increasingly used in Latin America as clinical trials grow in the region. Bioaccess, a Miami-based CRO focused on Latin America, leverages AI specifically for accelerating regulatory dossier preparation, investigator matching, and patient recruitment in countries such as Colombia, Panama, and Brazil. Syneos Health is a global CRO that incorporates AI for late-stage trials and has expanded operations in Latin America, supporting diverse medical device and drug trials.
Latin America is rapidly becoming a strategic hub for AI-enabled clinical trials because of its diverse population, cost advantages, and advancing digital health infrastructure. Companies like Bioaccess benefit from AI tools to streamline translation, document review, and regulatory submissions tailored to Latin American markets. IQVIA and Medidata utilize AI to improve patient screening and trial design efficiency, addressing challenges unique to the region such as heterogeneous data and complex regulatory environments. Syneos Health’s regional presence strengthens late-stage trial capacity by combining AI-driven analytics with local expertise. These firms collaborate with local healthcare providers and regulators to expedite ethical approvals and optimize patient recruitment, thus positioning Latin America as a key testing ground for AI-based clinical research.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the AI-based Clinical Trials by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively using AI in clinical trials with significant participation in Latin America include IQVIA, Medidata Solutions (part of Dassault Systèmes), Bioaccess, and Syneos Health. IQVIA stands out as a major global CRO leveraging AI for optimizing clinical trial design, patient recruitment, and data analysis, and has a strong presence in Latin America’s emerging markets. Medidata is a leader in AI-driven clinical trial platforms, providing tools for data management and trial execution, increasingly used in Latin America as clinical trials grow in the region. Bioaccess, a Miami-based CRO focused on Latin America, leverages AI specifically for accelerating regulatory dossier preparation, investigator matching, and patient recruitment in countries such as Colombia, Panama, and Brazil. Syneos Health is a global CRO that incorporates AI for late-stage trials and has expanded operations in Latin America, supporting diverse medical device and drug trials.
Latin America is rapidly becoming a strategic hub for AI-enabled clinical trials because of its diverse population, cost advantages, and advancing digital health infrastructure. Companies like Bioaccess benefit from AI tools to streamline translation, document review, and regulatory submissions tailored to Latin American markets. IQVIA and Medidata utilize AI to improve patient screening and trial design efficiency, addressing challenges unique to the region such as heterogeneous data and complex regulatory environments. Syneos Health’s regional presence strengthens late-stage trial capacity by combining AI-driven analytics with local expertise. These firms collaborate with local healthcare providers and regulators to expedite ethical approvals and optimize patient recruitment, thus positioning Latin America as a key testing ground for AI-based clinical research.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
